Type 2 Diabetes

Reducing Eating Speed May Prevent Obesity in Type 2 Diabetes

Reducing Eating Speed May Prevent Obesity in Type 2 Diabetes

Eating speed can affect changes in obesity, body mass index, and waist circumference in patients with type 2 diabetes.

T2D May Play a Protective Role Against Developing Aortic Diseases

T2D May Play a Protective Role Against Developing Aortic Diseases

By

The novel findings in this study suggest that patients with type 2 diabetes have a significantly reduced risk for short-term mortality after hospitalization for aortic aneurysm compared with population-based control subjects.

Diabetes Mortality Trends in Adults With Low eGFR, No Albuminuria

Diabetes Mortality Trends in Adults With Low eGFR, No Albuminuria

A recent study examined mortality trends in adults with diabetes and assessed albumin-to-creatinine ratios and estimated glomerular filtration rates.

Risk Factors for Diabetes May Be Identified 20 Years Before Diagnosis

Risk Factors for Diabetes May Be Identified 20 Years Before Diagnosis

Risk of developing type 2 diabetes is associated with subtle elevations of glucose and lipids more than 20 years before diagnosis.

Physician-Patient Communication Key for Improving Diabetes Care

Physician-Patient Communication Key for Improving Diabetes Care

Diabetes care can be improved with enhanced communication between providers and patients and improved communication between members of the primary care team.

Metformin Safe in T2D With Moderate to Severe Chronic Kidney Disease

Metformin Safe in T2D With Moderate to Severe Chronic Kidney Disease

By

This is the first study to have validated a metformin dose adjustment as a function of the estimated glomerular filtration rate in patients with type 2 diabetes and chronic kidney disease.

Increased Risk for Severe Hypoglycemic Events Associated With CV Outcomes

Increased Risk for Severe Hypoglycemic Events Associated With CV Outcomes

By

The bidirectional relationship between severe hypoglycemic events and cardiovascular outcomes suggests that there may be a common "frail" type 2 diabetes phenotype of patients who are susceptible to both of these events.

Women With T1D, T2D Receiving Increased Intervention in Pregnancy

Women With T1D, T2D Receiving Increased Intervention in Pregnancy

By

Higher rates of operative delivery and falling gestational age at delivery suggest that this is either reflected by, or despite, increasing obstetric intervention.

Safety, Efficacy of Semaglutide for Inadequately Controlled T2D

Safety, Efficacy of Semaglutide for Inadequately Controlled T2D

By

Patients with type 2 diabetes who received once-weekly semaglutide had statistically greater reductions in HbA1c and body weight compared with those treated with dulaglutide.

Two New Diabetes Medications Now Available

Two New Diabetes Medications Now Available

By

Two recently-approved diabetes treatments, a semaglutide injection and an insuline aspart injection, are now available in pharmacies across the United States.

Updated <I>Standards of Medical Care in Diabetes</I> Focuses on Cardiovascular Disease

Updated Standards of Medical Care in Diabetes Focuses on Cardiovascular Disease

By

ADA's recommendations reflect the latest advances in evidence-based research to improve care for millions of people with diabetes.

Assessing the Link Between Chronic Migraine and Insulin Resistance

Assessing the Link Between Chronic Migraine and Insulin Resistance

By

Study assessed the relationship of fasting neuropeptide Y with insulin resistance, β-cell function, and glucagon-like peptide-1 secretion in nonobese female patients with chronic migraine.

Remission of T2D Possible With Strict Glycemic Control

Remission of T2D Possible With Strict Glycemic Control

Stricter glycemic control during short-term intensive insulin therapy for newly diagnosed type 2 diabetes patients is associated with a higher likelihood of remission at 1 year.

Higher Risk for Adverse Pregnancy Outcomes in Women With Pregestational Diabetes on Metformin

Higher Risk for Adverse Pregnancy Outcomes in Women With Pregestational Diabetes on Metformin

By

Higher risks for adverse pregnancy outcomes observed in pregnant women taking metformin for pregestational diabetes are not a result of metformin, but diabetes.

Duration of Prediabetes, Diabetes Independently Associated With Subclinical Atherosclerosis, Cardiac Dysfunction

Duration of Prediabetes, Diabetes Independently Associated With Subclinical Atherosclerosis, Cardiac Dysfunction

By

Data emphasize the importance of early identification and management of those at risk for diabetes and prediabetes in order to limit exposure to the adverse cardiovascular effects of a longer duration of these conditions.

Type 2 Diabetes Treatment Adherence Varies Across Medication Classes

Type 2 Diabetes Treatment Adherence Varies Across Medication Classes

There is considerable variation in adherence across medication classes for the treatment of type 2 diabetes, including sulfonylureas, thiazolidinediones, and metformin.

Effects of Sitagliptin on Standardized Insulin Secretion, B-Cell Function

Effects of Sitagliptin on Standardized Insulin Secretion, B-Cell Function

A single dose of the dipeptidyl peptidase-4 inhibitor sitagliptin is associated with increased standardized insulin secretion, with no impact on β-cell glucose sensitivity.

Gestational Diabetes May Increase Risk for Hypertension, Ischemic Heart Disease, T2D

Gestational Diabetes May Increase Risk for Hypertension, Ischemic Heart Disease, T2D

By

Clinical guidelines should include postpartum screening and management for all cardiovascular risk factors in women diagnosed with gestational diabetes and not restrict it to diabetes.

No Increased Risk for Type 2 Diabetes, Hypertension in Living Kidney Donors

No Increased Risk for Type 2 Diabetes, Hypertension in Living Kidney Donors

Living kidney donors have no increased risks for all-cause mortality, cardiovascular disease, hypertension, type 2 diabetes, or adverse psychological health outcomes.

T1D, T2D May Have Protective Effects on Risk for Migraine

T1D, T2D May Have Protective Effects on Risk for Migraine

By

Results from a study investigating diabetes and migraine in the Norwegian population show that type 1 and type 2 diabetes were significantly associated with a decreased risk for migraine.

Balance Training May Reduce Fall Risk in Older Adults With T2D

Balance Training May Reduce Fall Risk in Older Adults With T2D

By

Balance training interventions (supervised and unsupervised) led to significant improvements in a number of physiological measures, ultimately reflected in a decline in fall risk for older adults with T2D.

Sulfonylureas May Increase Tuberculosis Risk in Type 2 Diabetes

Sulfonylureas May Increase Tuberculosis Risk in Type 2 Diabetes

By

Patients with type 2 diabetes treated with sulfonylureas may be at a higher risk of contracting tuberculosis, compared with patients treated with metformin.

Adding Ezetimibe to Statin Therapy: Cardiovascular Outcomes in Diabetes

Adding Ezetimibe to Statin Therapy: Cardiovascular Outcomes in Diabetes

By

In patients with an acute coronary syndrome and LDL-C >50 mg/dL, healthcare providers should consider adding ezetimibe to statin therapy to reduce the risk of cardiovascular events.

Type 1 Diabetes Associated With Higher Rates of Serious Infection

Type 1 Diabetes Associated With Higher Rates of Serious Infection

Patients with diabetes had higher rates for all 19 infection categories with the highest incidence rate ratios seen for bone and joint infections, sepsis, and cellulitis.

First-line Metformin Use for Type 2 Diabetes Increases Over Last Decade

First-line Metformin Use for Type 2 Diabetes Increases Over Last Decade

Among patients with type 2 diabetes initiating antidiabetes drugs, first-line use of metformin has increased since 2005.

Differences in Modifiable Risk Factors Contribute to Increased T2D Risk Among Blacks

Differences in Modifiable Risk Factors Contribute to Increased T2D Risk Among Blacks

By

Differences in traditional modifiable diabetes risk factors between black and white individuals may contribute to the racial disparity in diabetes incidence in middle age.

Effect of Intra-Articular Depot Betamethasone on Insulin Resistance in T2D

Effect of Intra-Articular Depot Betamethasone on Insulin Resistance in T2D

By

Patients identified with increased insulin resistance following intra-articular corticosteroid injection or any systemic steroid treatment might need a special emphasis regarding management and followup.

Takeout Food May Increase Adverse Health Consequences in Children

Takeout Food May Increase Adverse Health Consequences in Children

By

Efforts to reduce takeaway meal consumption in children could have both short-term and long-term health benefits.

Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined

Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined

By

In this phase 3 study, statistically and clinically meaningful improvements in HbA1c, body weight, and the proportion of patients achieving goal HbA1c <7% (53mmol/mol) were demonstrated with 2 doses of ITCA 650 vs placebo.

Higher BUN May Increase Risk for Incident Diabetes

Higher BUN May Increase Risk for Incident Diabetes

By

Findings showed that as the estimated glomerular filtration rate decreased and the blood urea nitrogen level increased, the risk for incident diabetes became progressively more pronounced.

Sign Up for Free e-Newsletters

CME Focus